Securities Code: 002370 Securities Abbreviation: Asia-Pacific Pharmaceutical Announcement No.: 2026-038
Zhejiang Asia-Pacific Pharmaceutical Co., Ltd. 2026 First Quarter Report
The Company and all members of the Board of Directors guarantee the content of the information disclosure is true, accurate, and complete, with no false records, misleading statements, or major omissions.
Key Content Prompts:
- The Board of Directors, Directors, and Senior Management guarantee the authenticity, accuracy, and completeness of the quarterly report, with no false records, misleading statements, or major omissions, and shall bear individual and joint legal liabilities.
- The Company's principal, the person in charge of accounting, and the head of the accounting department (accounting supervisor) declare: Guarantee the authenticity, accuracy, and completeness of the financial information in the quarterly report.
- Has the first quarter financial report been audited? No Yes
I. Main Financial Data
(I) Main Accounting Data and Financial Indicators
Does the company need to retrospectively adjust or restate previous year's accounting data? No Yes
| This Reporting Period | Previous Year Period | Year-on-Year Change (%) | |
|---|---|---|---|
| Operating Revenue (RMB) | 59,576,342.35 | 64,550,537.91 | -7.71% |
| Net Profit Attributable to Shareholders of Listed Companies (RMB) | -2,587,529.71 | -7,803,212.71 | 66.84% |
| Net Profit Attributable to Shareholders of Listed Companies After Deducting Non-Recurring Gains and Losses | -4,368,585.08 | -7,563,796.43 | 42.24% |
| Net Cash Flow from Operating Activities (RMB) | -2,198,891.81 | 11,574,799.13 | -119.00% |
| Basic Earnings Per Share (RMB/share) | -0.0035 | -0.0105 | 66.67% |
| Diluted Earnings Per Share (RMB/share) | -0.0035 | -0.0105 | 66.67% |
| Weighted Average Return on Equity | -0.23% | -0.79% | 0.56% |